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The BH3 interacting-domain death agonist (BID) is a pro-apoptotic protein involved in
death receptor-induced and mitochondria-mediated apoptosis. Recently, it has also
been suggested that BID is involved in the regulation of inflammatory responses
in the central nervous system. We found that BID deficiency protected organotypic
hippocampal slice cultures in vitro from neuronal injury induced by oxygen-glucose
deprivation. In vivo, BID-knockout (KO) mice and wild type (WT) mice were subjected
to 60 min of transient middle cerebral artery occlusion (tMCAO) to induce focal cerebral
ischemia, and allowed to recover for 24 h. Infarct volumes and functional outcome were
assessed and the inflammatory response was evaluated using immunofluorescence,
Western blotting, quantitative PCR (qPCR) and Mesoscale multiplex analysis. We
observed no difference in the infarct volume or neurological outcome between BID-KO
Abbreviations: ACA, Anterior cerebral artery; BA, Basilar artery; BCL-2, B-cell lymphoma-2; BID, BH3 interacting-domain
death agonist; CCD, Charge-coupled device; CCL-2, Chemokine (C-C motif) ligand 2; CXCL1, Chemokine (C-X-C
motif) ligand 1; ECL, Enhanced chemiluminescence; ERK, Extracellular signal-regulated kinase; GAPDH, Glyceraldehyde
3-phosphate dehydrogenase; GFAP, Glial fibrillary acidic protein; HPRT1, Hypoxanthine phosphoribosyltransferase 1;
HRP, Horse radish peroxidase; IBA1, Ionized calcium-binding adaptor molecule 1; IFNγ, Interferon-γ; IL, Interleukin; KO,
Knockout; MCA, Middle cerebral artery; NF-κB, Nuclear factor κB; NOD, nucleotide-binding oligomerization domain
containing; OGD, Oxygen-glucose deprivation; OHSC, organotypic hippocampal slice cultures; ON, over night; PFA,
Paraformaldehyde; qPCR, Quantitative PCR; PcomA, Posterior communicating artery; PVDF, Polyvinylidene difluoride;
rCBF, Regional cerebral blood flow; RT, Room temperature; SCA, Superior cerebellar artery; tBID, truncated BID; TFIIB,
Transcription initiation factor IIB; tMCAO, Transient middle cerebral artery occlusion; TNF, Tumor necrosis factor; WT,
Wild-type; γTri-DAP, L-Ala-γ-D-Glu-meso-diaminopimelic acid.
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and WT mice. The inflammatory response was reduced by BID deficiency as indicated
by a change in microglial/leukocyte response. In conclusion, our data suggest that
BID deficiency is neuroprotective in an in vitro model and modulates the inflammatory
response to focal cerebral ischemia in vivo. However, this is not translated into a robust
neuroprotection in vivo.
Keywords: BID, focal cerebral ischemia, organotypic hippocampal slice cultures, neuronal injury, inflammation
INTRODUCTION
Within minutes following the incidence of an ischemic stroke,
necrotic cell death is initiated in the core region of the infarct.
In the ischemic penumbra, nutrient deprivation is less severe
and the damage is transiently reversible. Here, cells often die
from apoptosis initiated hours after the onset of ischemia in
a process that may last for days (Astrup et al., 1981; Zivin,
1998; Mergenthaler et al., 2004; Lorz and Mehmet, 2009). The
BH3 interacting-domain death agonist (BID) is a proapoptotic
B-cell lymphoma-2 (BCL-2) family protein involved in death
receptor-induced apoptosis. BID links death receptor signaling
to the mitochondrial BCL-2 family-controlled apoptotic pathway
(Wang et al., 1996; Engel et al., 2011). The involvement of
BID in apoptosis is believed to be stimulated by cleavage of
full length-BID in the cytosol to form truncated BID (tBID).
This leads to translocation of tBID to the outer mitochondrial
membrane resulting in cytochrome c release and thereby
apoptosis (Broughton et al., 2009; Ren et al., 2010; Engel et al.,
2011).
BID has been considered a significant player in cell
death following focal cerebral ischemia, as BID-knockout
(KO) mice developed smaller infarcts than wild type (WT)
mice (Plesnila et al., 2001; Yin et al., 2002). In addition to
apoptosis, it has been suggested that BID is also involved
in inflammatory signal transduction in a process independent
of its proapoptotic properties. This has been tested in vitro
using BID-deficient microglia, astrocytes, macrophages and
human colon adenocarcinoma (HT29) cells, and in serum
from mice exposed to intraperitoneal injections of the bacterial
peptide L-Ala-γ-D-Glu-meso-diaminopimelic acid (γTri-DAP;
Mayo et al., 2011; Yeretssian et al., 2011; König et al., 2014).
In these studies BID deficiency resulted in decreased levels of
proinflammatory cytokines and chemokines (Mayo et al., 2011;
Yeretssian et al., 2011). Furthermore, it has been described
that BID deficiency is associated with lower levels of tumor
necrosis factor (TNF), interleukin (IL)-6 and chemokine (C-
C motif) ligand 2 (CCL-2) in a disease model for sepsis
(Chung et al., 2010) and with higher levels of IL-1β and
chemokine (C-X-C motif) ligand 1 (CXCL1) in experimental
inflammatory arthritis (Scatizzi et al., 2007). In addition to
altering the expression pattern of cytokines and chemokines, BID
deficiency has also been shown to reduce neutrophil infiltration
following experimental peritonitis in mice (Yeretssian et al.,
2011), and to impair phagocytic properties of microglia and
macrophages (Mayo et al., 2011). Mechanistically, it has been
proposed that the observed effects of BID deficiency on
inflammation is attributed to the observation that full-length
BID is required for nucleotide-binding oligomerization domain
containing (NOD) 1 and NOD2 signaling thereby influencing
extracellular signal-regulated kinase (ERK) and nuclear factor
κB (NF-κB) signaling (Yeretssian et al., 2011). However, this
hypothesis has been questioned (Mayo et al., 2011; Nachbur
et al., 2012). In the present study, we examined the effect of BID
deficiency in an in vitro model of ischemic neuronal injury, and
examined the effect of BID deficiency on lesion size, functional
outcome and inflammation in response to focal cerebral ischemia
in mice.
MATERIALS AND METHODS
Mice
BID-KO mice (Kaufmann et al., 2007) were provided by
Prof. Andreas Strasser, WEHI, Melbourne, Australia and have
previously been described (Kaufmann et al., 2007; König
et al., 2014). The BID-KO mice were generated on an inbred
C57BL/6 background, using C57BL/6-derived embryonic stem
cells. Corresponding C57BL/6 WT mice were from the same
background. For focal ischemia experiments, male mice aged
9–11 weeks weighing 25–28 g were used. Mice were housed
in numbers of five per cage under diurnal lighting conditions,
allowed free access to food and water, and cages were provided
with shelter, and bedding and nesting material. All animal
work was performed with ethics approval and under licenses
granted by the Irish Department of Health and Children. Animal
procedures were reviewed and approved by the RCSI Research
Ethics Committee.
DNA Extraction and Genotyping
Mice tail DNA was extracted using High Pure PCR Template
Preparation Kit (Roche, UK). Genotyping was performed
using specific primers as follows: 5′-GGT-CTGTGTGG
AGAGCAAAC-3′ (common), 5′-TCAGGTGCCAGTGGAGA
TGAACTC-3′ (wild type allele-specific) and 5′-GAGTC
ATACTTACTTCCTCCGAC-3′ (mutant allele-specific) for BID.
Preparation of Organotypic Hippocampal
Slice Cultures
Organotypic hippocampal slices cultures (OHSCs) were
prepared according to a previously described procedure
(Stoppini et al., 1991; Kristensen et al., 2001; Bonner et al., 2010)
with minor modifications. The brains from postnatal day 10
WT and BID-KO mouse pups were isolated and transferred
to dissection medium containing HBSS (Invitrogen), 20 mM
HEPES, 100 U/ml pen/strep, and 6.5 mg/ml D-glucose (Sigma
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Aldrich, Ireland). Brains were dissected in half and each
hemisphere was separated to expose the hippocampi, which
were separated from the neighboring thalamus and basal ganglia
and the septo-hippocampal connection severed with a scalpel.
Isolated hippocampi were placed on a McIlwain tissue chopper
(Mickle Laboratory Engineering, UK), aligned perpendicularly
to the chopper blade and cut into 450 µm thick sections.
The slices were transferred into fresh dissection medium
and selected for clear hippocampal morphology (intact CA
regions and dentate gyrus) and placed on the porous (0.4 µm)
membrane of Millicell inserts (Merck Millipore, USA). The
inserts were placed in six-well tissue culture plates with 1 ml
of culture medium consisting of MEM supplemented with
25% horse serum, 4 mM L-glutamine, 6 mg/ml D-glucose,
2% B27 and 50 U/ml pen/strep. The slices were maintained
in a humidified incubator with 5% CO2 at 35◦C with media
changes every second day. All experiments were performed at
DIV10.
Oxygen–Glucose Deprivation (OGD) in
OHSCs
Slices were tested for viability with Propidium Iodide (PI) added
to the medium at a final concentration of 5 µg/ml for 15 min
before the OGD experiments. Healthy slices from WT and
BID-KO mice were transferred to a hypoxic chamber (COY
Lab Products, USA). The hypoxic chamber had an atmosphere
comprising 1.5% O2, 5% CO2, and 85% N2, and the temperature
was maintained at 35◦C. The slices were transferred to wells
containing preequilibrated and deoxygenated OGD medium
(bubbled with N2 for 1 h before use). The OGD medium
consisted of the following: 2 mM CaCl2, 125 mM NaCl, 25 mM
NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM MgSO4 and
mM 10 sucrose, pH 6.8. After 180 min of OGD, the slices were
transferred to fresh oxygenated culture medium and placed in
normoxic conditions (21% O2 and 5% CO2), and PI uptake was
observed following a 24 h period. sham slices were free from
OGD. For experiments involving the use of NMDA antagonist,
MK-801, (10 µM/L) was added pre, during and post OGD
treatment.
PI Staining and Quantification of Injury
within the OHSC
Neuronal injury was assessed by means of PI staining
as previously described (Bonner et al., 2010). Fluorescence
images were acquired with an Eclipse TE 300 inverted
microscope (Nikon, Japan) and a 4× dry objective with
Wasabi Software version 5.0 (Hamamatsu Photonics, Germany).
Illumination and exposure (camera and exposure time) were
kept constant throughout each series of recordings and between
experiments. The CA1 region was selected from WT and BID-
KO hippocampal slices after OGD treatment, and the mean
fluorescent intensity was determined. The regional gray-level
intensity was measured using the Wasabi interactive tool,
background gray-level was accounted for and neuronal injury
was expressed as a percentage of total injury (0.5 mM NMDA
treatment for 1 h and recovery for 24 h). Data were arranged
from at least three similarly treated slices and at least three
independent experiments were carried out for each condition.
Induction of Transient Middle Cerebral
Artery Occlusion (tMCAO)
Focal cerebral ischemia was induced by transient middle cerebral
artery occlusion (tMCAO) as previously described (D’Orsi
et al., 2015). Briefly, mice were anesthetized with a mixture
of 62% N2O, 33% O2 and 5% isoflurane (Abbott, Ireland)
for 45 s and maintained with 65% N2O, 33% O2 and 2%
isoflurane. Body temperature was maintained at ∼37◦C using
a feedback-controlled heating pad connected to a rectal probe
(Heater Control Module; FHC). The eyes were protected by
ointment (Bayer, Germany) and an analgesic (Buprenorphine
[0.05 mg/kg], Reckitt, UK) was administrated subcutaneously.
A flexible laser-Doppler probe (5001 Master, Sweden) was glued
onto the exposed left parietal skull over themiddle cerebral artery
(MCA) territory for continuous monitoring of regional cerebral
blood flow (rCBF). A silicone-coated 8-0 nylon monofilament
was introduced through the left common carotid artery and
advanced carefully into the internal carotid artery up to the
level of the MCA where a drop in rCBF to less than 20% of
baseline indicated a successful occlusion of the MCA. Wounds
were sutured, the laser-Doppler probe was removed, and mice
were kept at 34◦C and allowed to wake up. Sixty minutes
after MCAO, mice were shortly re-anesthetized and ischemia
was terminated by removal of the silicone-coated filament.
This surgical procedure has been thoroughly evaluated in our
laboratory to confirm reperfusion after filament removal.
For postsurgical pain treatment, analgesic was administered
every 8 h after surgery for the first 24 h. Sham mice underwent
the same procedure except for the actual occlusion of the MCA.
Group Size and Study Design of In Vivo
Experiments
The size of the ischemic infarct was measured in a study in which
BID-KO (n = 8) and WT (n = 8) mice were allowed to survive
for 24 h after 60 min of tMCAO. In order to evaluate the effect
of ischemia on inflammation BID-KO (n = 3) and WT (n = 3)
mice subjected to sham surgery were included. In the analyses
of the cerebrovascular anatomy a total of 7 BID-KO and 8 WT
mice were included. The strain of the individual mice was blinded
to the person performing surgeries and the following analyses.
Three mice were excluded in the analyses due to insufficient
infarct formation or experimental flaws. No mice died during the
experiment.
Behavioral Analyses
Behavioral tests were performed in a blinded fashion prior to and
after tMCAO in order to evaluate functional outcome 24 h after
tMCAO.
Neurodeficit Score
To evaluate motor function of mice exposed to tMCAO,
a scoring system from 0–4 was applied (Nagayama et al.,
1999; McCullough et al., 2005) where 0: no observed deficits;
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1: forelimb weakness and torso turning to the ipsilateral side
when held by tail, but no circling; 1.5: both circling and non-
circling walking pattern observed; 2: circling, no straight walking;
3: leaning to the contralateral side at rest; 4: no spontaneous
motor activity or barrel rolling. All mice were scored just before
reperfusion and again 24 h after reperfusion.
Vertical Rope Test
To objectively evaluate the strength of the mice, a vertical
rope test was included (modified from Kashiwabuchi et al.,
1995 and Brooks and Dunnett, 2009). A 1 cm thick rope was
hanging vertically 20 cm from the ground where an open cage
containing bedding material was placed. The rope was covered
with a plastic tube, which prevented the mice from climbing,
except from the lowest 6 cm which where covered by surgical
tape allowing the mice to hold on. The mice were held by
their tail and the rope was tilted slightly towards the mice to
make sure they grabbed the rope with all four limbs positioned
head up. The tail and the rope were carefully released, and
the time the mice spent on the rope was measured in four
trails with at least 5 min in between. Mice were tested 24 h
before and 24 h after tMCAO. The trial was included if the
mouse stayed more than 3 s and less than 120 s on the rope,
and the average time mice spent on the rope was used in the
analysis.
Tissue Preparation
Mice were killed by an overdose of Pentobarbital sodium
(Dolethal, LURE Cedex, France) followed by 25 ml saline
perfusion. Brains were immediately removed, snap frozen in
dry ice cooled isopentane and stored at −80◦C until further
processing. Fresh frozen brains were cut coronally in five parallel
series on a cryostat (Leica CM 1950, Germany). Three of
the series were cut into 10 µm thick sections and collected
on Superfrost Plus slides (Thermo Scientific, Germany) with
0.5 mm between each section for infarct volume estimations and
immunohistochemistry. The rest of the brain was cut into 50 µm
thick sections and collected in Eppendorf tubes for quantitative
PCR (qPCR), Western blotting and mesoscale multiplex analysis.
For the analyses of the cerebrovascular anatomy, saline
perfusion was followed by perfusion with 25 ml of 4%
paraformaldehyde (PFA) and then by 0.8 ml of cresyl violet
acetate solution (Sigma Life Science, MA, USA). Brains were
stored in 4% PFA until further processed.
Infarct Volume Estimations
Brain sections were stained with cresyl violet acetate (Sigma
Life Science, MA, USA) and microphotographs were acquired
using a 1.25 magnification lens (Leica DM 4000 B, Germany).
The area of the infarct, the area of the noninfarcted ipsilateral
hemisphere and the area of the contralateral hemisphere were
measured using the software Leica Application Suite (LAS V3.7),
and the direct and indirect infarct volumes and brain sizes were
estimated according to the Cavalieri principle and as previously
described (Gröger et al., 2005). In addition, a rostrocaudal infarct
distribution analysis was performed comparing the infarct area
every 1 mm from 2–10 mm from the frontal pole.
Immunofluorescence
Air-dried tissue slides were fixed in 4% formalin, permeabilized
in 3% Triton X-100 and blocked in 5% donkey serum. Sections
were then incubated at 4◦C overnight (ON) in blocking media
with rabbit anti-ionized calcium-binding adaptor molecule 1
(IBA1; WAKO, VA, USA, 1:500) and mouse anti-glial fibrillary
acidic protein (GFAP; Life Technologies, CA, USA, 1:500).
After rinsing the slides in 0.1% Triton X-100 they were
incubated in secondary Alexa-488-conjugated rabbit anti-goat
IgG (Life Technologies, CA, USA, 1:500) for 1 h at room
temperature (RT), thoroughly rinsed in 0.1% Triton X-100
followed by incubation with Alexa-568-conjugated goat anti-
mouse IgG (Life Technologies, CA, USA, 1:500) 1 h at RT.
Hoechst staining was added (1:1000) for 10 min and sections
were mounted in FlourSave (Merck Millipore, USA). Digital
images were acquired on a fluorescent microscope (Leica DM
4000 B, Germany) at 20× magnification from seven randomly
chosen locations surrounding the infarct in border zone normal
appearing ipsilateral cortex and corresponding locations on the
contralateral hemisphere. GFAP and IBA1 positive cells were
counted and the average number of cells (cells per field of view)
was used in the analyses.
Evaluation of Mouse Cerebrovascular Anatomy
The cerebrovascular anatomy was analyzed in order to
compare the posterior communicating arteries (PcomAs) and
the MCA territory between BID-KO mice and WT mice.
After cresyl violet perfusion brains were removed and the
circle of Willis was exposed by carefully pulling down
the cerebellum. Superiorly and inferiorly orientated pictures
were acquired on a camera connected to a surgical microscope
(Leica DFC29, Germany). The diameters of the PcomAs were
measured at the widest point and the diameter of the basilar
artery (BA) was measured proximal to the posterior cerebral
arteries. The diameter of the PcomAs as a percentage of the
diameter of the BA was calculated and used in the analysis
(Kitagawa et al., 1998). The MCA territory was examined
by measuring the distance from the peripheral anastomoses
between the anterior cerebral artery (ACA) and the MCA
at 2, 4 and 6 mm from the frontal pole (Maeda et al.,
1999).
Western Blotting
Western blotting was performed on one series of whole brain
lysate by extracting proteins in a RIPA lysis buffer (Merck
Millipore, Denmark) containing a protease inhibitor cocktail
(Roche Diagnostics, Denmark), and protein concentrations were
estimated by the Bradford protein assay (Biorad, CA, USA) as
described previously (Lambertsen et al., 2009).
Proteins were resolved by SDS-PAGE on 4–12% Bis-Tris
gels (NupageTM, Invitrogen, Denmark) and transferred to
polyvinylidene difluoride (PVDF) membranes. SeeBlue Plus2
prestained standard (LC5925 Invitrogen, Denmark) was used
as molecular weight marker. Following blocking in 5% non-
fat dry milk plus 0.05% Tween-20, membranes were incubated
ON at 4◦C with rabbit anti-BID (Enzo Life Sciences, USA,
1:1000), rabbit anti-GFAP (DAKO, Denmark, 1:1000), rabbit
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anti-pERK1/2 (Cell Signaling, 1:2000), rabbit anti-pJNK1/2 (Cell
Signaling, 1:1000), mouse anti-α-actin (Chemicon, USA, 1:8000),
rabbit anti-pIKKα/β (Cell Signaling, 1:1000), rabbit anti-pp38
(cell signaling, 1:1000) or mouse anti-transcription initiation
factor IIB (TFIIB; Cell Signaling, 1:1000) in blocking solutions.
After thorough wash in TBS-0.05% Tween20, membranes were
incubated in horseradish peroxidase (HRP)-conjugated goat
anti-rabbit IgG (Cell Signaling, 1:1000) or HRP-conjugated
rabbit anti-mouse IgG (DAKO, 1:2000) for 1 h at RT.
For detection of HRP activity, a luminol-based enhanced
chemiluminescence (ECL) substrate (Thermo scientific, MA,
USA) was used and light emission was captured on a
charge-coupled device (CCD) camera (2200 PRO Gel Logic
Carestream, USA). Mice included in the Western blot analysis
for GFAP were selected based on their infarct size choosing
the mice with infarct volumes close to the estimated mean
infarct volume within each treatment group. Densitometry of
Western blots was performed using Image J analysis software
(NIH) in accordance with the Image J developers guidelines
and data are presented relative to the level of α-actin or
TFIIB.
Mesoscale Multiplex Analysis
Whole brain pooled protein samples (23–28 mg/ml) from BID-
KO andWTmice exposed to tMCAO (pool from five mice (BID-
KO) and six mice (WT)) and BID-KO and WT mice subjected
to sham surgery (pool from three mice in each group) were
applied and protein extractions were prepared as described for
Western blotting. To measure cytokine protein levels by the
MSD electrochemiluminescence proinflammatory mouse V-Plex
Plus Kit (IFNγ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70,
CXCL1, TNF; K15012C, Mesoscale) we used a SECTOR Imager
6000 (MSD Mesoscale Discovery, USA) Plate Reader according
to the manufacturer’s instructions. Samples were diluted twofold
in Diluent 41 prior to measurement and 25 µl was loaded in
each well. Data was analyzed using MSD Discovery Workbench
software.
Quantitative PCR Analysis
qPCR was performed to examine and compare the relative
mRNA expression of BAK, BAX, Bcl2, Bclxl, CD11b, CD38,
CXCL1, IL-1β, IL-6, IL-10 and TNF between BID-KO mice and
WT mice as described previously (Clausen et al., 2005, 2014).
Total RNA was extracted using RNeasy mini kit (QIAGEN,
Netherlands) and cDNAwas synthesized using 2µg of total RNA
and reagents from a High-Capacity cDNA Reverse Transcription
Kit (Life technology, CA, USA) according to the manufacturer’s
instructions. qPCR analyses were performed using the following
conditions: 2 min at 50◦C, 10 min at 95◦C, 45 cycles of 15 s
at 95◦C followed by 1 min at annealing temperature, 15 s at
95◦C, 3 min at 60◦C and finally 15 s at 95◦C. TaqMan chemistry
was applied for all analyses with the exception of BAK for
which SYBRgreen chemistry was applied. Primer sequences can
be found in Table 1. Expression results were reported relative
TABLE 1 | Primers and probes applied in qPCR analyses.
Primer/probe Sequence Cat.no./Supplier
BAK F′ 5′-CCTTCTGAACAGCAGGTTGC-3′ TagCopenhagen
BAK R′ 5′-GACCCACCTGACCCAA-3′ TagCopenhagen
BAX TaqMan assay Not available Mm00432051_m1, Life Technologies
Bcl2 TaqMan assay Not available Mm00477631_m1, Life Technologies
Bclxl TaqMan assay Not available Mm00437783_m1, Life Technologies
CD11b F′ 5′-CGGAAAGTGTGAGAGAACTGTTTC-3′ TagCopenhagen
CD11b R′ 5′-CTTATAATCCAAGGGATCACCGAATTT-3′ TagCopenhagen
CD11b probe 5′-TCTGTGATGACAACTAGGATCTTCGCAGC-3′ TagCopenhagen
CD38 Taqman assay Not available Mm00483146_m1, Life Technologies
CXCL1 F′ 5′-GCTGGGATTCACCTCAAGAAC-3′ TagCopenhagen
CXCL1 R′ 5′-TGTGGCTATGACTTCGGT-3′ TagCopenhagen
GAPDH F′ 5′-TGTCAAGCTCATTTCCTGGTATGA-3′ TagCopenhagen
GAPDH R′ 5′-CTTACTCCTTGGAGGCCATGTAG-3′ TagCopenhagen
GAPDH probe 5′-TCCACCACCCTGTTGCTGTAGCCG-3′ TagCopenhagen
HPRT1 F′ 5′-GTTAAGCAGTACAGCCCCAAAATG-3′ TagCopenhagen
HPRT1 R′ 5′-AAATCCAACAAAGTCTGGCCTGTA-3′ TagCopenhagen
HPRT1 probe 5′-AGCTTGCTGGTGAAAAGGACCTCTCGAAGT-3′ TagCopenhagen
IL-1β F′ 5′-CTTGGGCCTCAAAGGAAAGAA-3′ TagCopenhagen
IL-1β R′ 5′-AAGACAAACCGTTTTTCCATCTTC-3′ TagCopenhagen
IL-1β Probe 5′-AGCTGGAGAGTGTGGAT-3′ TagCopenhagen
IL-6 F′ 5′-CTGCAAGAGACTTCCATCCAGTT-3′ TagCopenhagen
IL-6 R′ 5′-GAAGTAGGGAAGGCCGTGG-3′ TagCopenhagen
IL-10 F′ 5′-AGGACTTTAAGGGTTACT-3′ TagCopenhagen
IL-10 R′ 5′-AATGCTCCTTGATTTCTG-3′ TagCopenhagen
TNF F′ 5′-TGGCCTCCCTCTCATCAGTTC-3′ TagCopenhagen
TNF R′ 5′-CCACTTGGTGGTTTGCTACGA-3′ TagCopenhagen
TNF probe 5′-TGGCCCAGACCCTCACACTCAGATCATC-3′ TagCopenhagen
Primers used for qPCR.
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 February 2016 | Volume 10 | Article 14
Martin et al. BID in Experimental Stroke
to the geometric mean of the expression of the housekeeping
genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
hypoxanthine phosphoribosyltransferase 1 (HPRT1).
Data Analyses
Analyses performed on digital images were carried out on
unmanipulated pictures (OHSC, infarct volume estimations,
immunofluorescence and evaluation of mouse cerebrovascular
anatomy). On the presented pictures the contrast has been
enhanced to allow readers to appreciate the details on small-scale
figures. In addition, a histology artifact has been covered in
FIGURE 1 | BID deletion in the applied knockout (KO) strain.
Representative PCR amplification of genomic DNA at the deleted bid gene
locus by bid genotyping reveals the appropriate PCR bands. M: 100 base pair
ladder; NC, negative control without the tail DNA template.
Figure 4A and arteries have been highlighted on zoom in pictures
in Figure 4B.
Quantitative data are presented as means ± SD and a
significant difference was accepted for p ≤ 0.05. OHSC
data, qPCR data, neurodeficit score, MCA territory, vertical
rope test and cell counting analyses were performed using a
repeated measure 2-way ANOVA, and PcomA comparisons,
infarct comparisons and Western blot densitometry by a
non-pared t-test. All statistical analyses were followed by
an appropriate post hoc test and performed using Prism 5
(GraphPad Software, Inc., CA, USA).
RESULTS
BID-Deficient Organotypic Hippocampal
Slice Cultures (OHSCs) are Partially
Protected from OGD-Induced Neuronal
Injury
PCR-based genotyping confirmed gene deletion in BID-KO
mice (Figure 1). To explore whether BID deficiency affords
neuroprotection against ischemic neuronal injury in a controlled
in vitro environment, we initially performed experiments
using OHSCs subjected to OGD. OGD is a widely used
in vitro model of ischemic injury that produces excitotoxic
and non-excitotoxic, apoptotic and necrotic neuronal injury
(Goldberg and Choi, 1993; Gwag et al., 1995; Kalda et al.,
1998).
OHSCs derived from WT and BID-KO mice were subjected
to OGD for 180 min in the presence or absence of the
NMDA receptor antagonist, MK-801, a treatment that blocks
the excitotoxic component of OGD-induced neuronal injury
FIGURE 2 | Organotypic hippocampal slice cultures (OHSCs) isolated from BID deficient mice show protection in response to oxygen-glucose
deprivation (OGD). The slices were sham-exposed or subjected to OGD conditions for 180 min in the absence or the presence of 10 µM MK-801 and allowed to
recover for 24 h. (A) Representative images of OHSCs derived from BID-KO and WT mice. (B) Quantification of injury assessed by PI staining 24 h post-treatment in
the CA1 subfield of the hippocampal slices. In the absence of MK-801, BID deficiency protected against neuronal injury (∗p = 0.024). Note the protection exerted by
MK-801 against OGD-induced neuronal injury of WT OHSCs. In BID-KO slice cultures MK-801 failed to reduce OGD-induced neuronal injury. Scale bar: 100 µm,
(n = 3–7 in each group, 2-way ANOVA, mean ± SD).
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(Goldberg and Choi, 1993). OHSCs slices were allowed to recover
under normoxic and normal glucose conditions over a 24 h
time period, after which neuronal injury was determined by PI
uptake (Figure 2A). Quantification of PI uptake demonstrated
that BID deficiency resulted in a significant neuroprotection
in the CA1 subfield if OGD was conducted in the absence
of MK-801 (p = 0.024). In WT OHSCs, MK-801 exerted
potent protection against OGD-induced neuronal injury as
expected (Figure 2B). Interestingly, MK-801 failed to further
reduce OGD-induced neuronal injury in BID-KO slice cultures,
suggesting that BID also mediated neuroprotective signaling
during OGD.
Cerebrovascular Anatomy of BID-KO Mice
We next explored the role of BID in the modulation of ischemic
neuronal injury in vivo. In order to be able to draw valid
conclusions from infarct volumetric analysis of BID-KO and
WT mice, we compared the cerebral vascular anatomy in
these mice by analyzing the MCA territory and the PcomAs
(Figure 3). Comparison of the MCA territory, by measuring
the distance from the peripheral anastomoses between the ACA
and the MCA at 2, 4 and 6 mm from the frontal pole, revealed
no differences between BID-KO and WT mice (p = 0.96;
Figure 3A). The PcomAs influence the collateral flow to the
territory distal to an occluded MCA (Carmichael, 2005) and
FIGURE 3 | Cerebrovascular anatomy. (A) The territory of the middle cerebral artery (MCA) was measured as the distance from the line of anastomoses between
the MCA and the anterior cerebral artery (ACA) to the midline at 2, 4 and 6 mm from the frontal pole. The cerebrovascular anatomy was analyzed by visualizing the
arteries with cresyl violet solution. We observed no significant difference between BID-KO mice and WT mice at any of these three sites (p = 0.96, n = 10–13 in each
group, 2-way ANOVA mean ± SD). (B) The diameters of the posterior communicating arteries (PcomAs) were measured at the widest part and the values were
calculated as a percentage of the basilar artery (BA) diameter. We found no significant difference between the two groups of mice (p = 0.11, n = 10–13 in each
group, non-paired t-test, mean ± SD). SCA: Superior cerebellar artery.
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the size of the PcomAs is a risk factor for ischemic infarction
(Schomer et al., 1994). Even though we observed great variations
in the development of the PcomAs in individual mice, there
was no significant difference in the size of the PcomAs as a
percentage of the diameter of the BA between the BID-KO
and WT mice (p = 0.11; Figure 3B). These findings suggest
that the cerebrovascular anatomy in BID-KO and WT mice is
comparable.
BID Deficiency did not Affect Infarct Size
or Functional Outcome after tMCAO
Infarct volume estimations were determined on the basis of
cresyl violet stained brain sections (Figure 4A). Comparison of
the mean infarct volume between BID-KO mice and WT mice
showed that BID deficiency did not affect infarct size 24 h after
60 min of MCAO (p = 0.45; Figure 4B). This was still valid
when infarct size was corrected for hemispheric swelling (indirect
infarct volume) and different brain sizes (data not shown). The
analysis of the rostrocaudal infarct distribution on individual
sections also showed no indication of a protective role of BID
deficiency after tMCAO (Figure 4C).
The behavioral outcome after tMCAO was evaluated using
a neurological deficit score and a vertical rope test. The
neurological deficit score was determined after surgery before
reperfusion, and again 24 h after reperfusion. We observed
no difference in the deficit mean score either before or after
reperfusion (p = 0.73). Also no difference was detected between
BID-KO mice and WT mice at any of the two time points
investigated (p = 0.52; Figure 4D). Using the vertical rope test, we
found that mice spent significantly less time on the rope 24 h after
reperfusion compared to before surgery (p = 0.013), however,
there was no significant difference between the two groups of
mice (p = 0.29; Figure 4E).
To examine whether the lack of effect on infarct size and
functional outcome was caused by altered expression level of
downstream apoptotic regulators in BID-KO mice, the mRNA
level of proapoptotic BAX and BAK, and antiapoptotic Bcl2
and Bclxl were analyzed by qPCR. However, we did not
detect any difference in expression level between the two
groups of mice for any of the examined apoptotic regulators
(p = 0.34 (BAK), p = 0.44 (BAX), p = 0.33 (Bcl2), p = 0.25
(Bclxl); Figure 5). We observed, however, reduced levels of
Bcl2 mRNA in infarcted vs. sham tissue, suggesting that the
FIGURE 4 | BID deficiency does not affect infarct formation or improves functional outcome after tMCAO. (A) Representative cresyl violet stained coronal
sections of brains from BID-KO mice and WT mice. IF: Infarct. (B) Direct infarct volume estimations showed no significant difference in infarct volume between
BID-KO mice and WT mice (p = 0.45, non-paired t-test). (C) This was also true for the rostrocaudale distribution analyses (p = 0.45, n = 6–7 in each group, mean ±
SD). (D) To evaluate the neurodeficit of mice we applied a scoring system from 0–4. We did not see a difference either before or after reperfusion (p = 0.73), just as
no difference was observed between BID-KO mice and WT mice at any of the two time points (p = 0.52, n = 6–7 in each group, 2-way ANOVA, mean ± SD).
(E) Mice spent significantly less time on the vertical rope 24 h following reperfusion compared to before surgery (#p = 0.013), however, there was no difference
between the two groups of mice at any of the time points (p = 0.29, n = 6–7 in each group, 2-way ANOVA, mean ± SD).
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FIGURE 5 | mRNA expression of downstream regulators of mitochondrial mediated apoptosis. The mRNA level of BAX, BAK, Bcl2 and Bclxl was examined
by qPCR on whole brain lysates and compared between BID-KO mice and WT mice exposed to tMCAO or sham surgery. We found no significant difference
between BID-KO mice and WT mice for any of the examined mitochondrial apoptosis regulator genes. Overall the direction of expression was however similar for all
four examined genes after tMCAO with the highest expression level found in BID-KO mice (BAK: p = 0.34, BAX: p = 0.44, Bcl2: 0.33, Bclxl: p = 0.25, n = 3 in each
sham group, n = 5–6 in each tMCAO group, mean ± SD). There was a significantly lower Bcl2 expression level in tMCAO mice compared to sham mice (#p = 0.047),
but not for BAX, BAK or Bclxl (p = 0.65, p = 0.42, p = 0.63 respectively, n = 3 in each sham group, n = 5–6 in each tMCAO group, non-paired t-test, mean ± SD).
mitochondrial apoptosis pathways were activated by cerebral
ischemia (Figure 5).
Microglial/Leukocyte Response to tMCAO
IBA1 is upregulated in microglia/leukocytes in response to focal
cerebral ischemia (Ito et al., 2001). In this study, estimation
of the number of IBA1+ microglia/leukocytes was performed
and compared between the ipsilateral hemisphere and the
contralateral hemisphere of mice exposed to tMCAO. We
observed no significant difference in the number of IBA1+
cells between BID-KO mice and WT mice on the contralateral
hemisphere or the ipsilateral hemisphere (p = 0.93). When
comparing the number of IBA1+ cells between the hemispheres
within the same group of mice, we found that there were
significantly more IBA1+ cells in the ipsilateral hemisphere of
WT mice compared to the contralateral hemisphere (p = 0.017).
This significant difference was not observed in the BID-
KO mice, suggesting altered activation or recruitment of
microglia/leukocytes in BID-KO mice in response to focal
cerebral ischemia (Figure 6A).
CD38 is a surface protein expressed on various immune cells.
It is considered to be a marker of activation known to hold
various immune regulatory functions (Quarona et al., 2013). To
investigate the immune cell response further, qPCR for CD38was
performed on whole brain mRNA extracts. In this analysis, we
observed a significantly higher level of CD38 in BID-KO mice
compared to WT mice after tMCAO (p = 0.05), whereas levels
were similar in mice exposed to sham surgery (Figure 6B). We
also examined themRNA level of themicroglia/leukocytemarker
CD11b. Here, we did not find a significant difference between
BID-KO mice and WT mice (p = 0.87; Figure 6C).
Astroglial Response to tMCAO
Immunohistochemistry for GFAP was performed, and an
estimation of the number of GFAP+ astrocytes pr. field of view
was carried out and compared between the ipsilateral hemisphere
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FIGURE 6 | Microglial/leukocyte response after transient middle cerebral artery occlusion (tMCAO). (A) IBA1 staining of ipsilateral and contralateral
hemisphere of one representative BID-KO and WT mouse exposed to tMCAO. We observed no significant difference in the number of IBA1+ cells per field of view
between BID-KO mice and WT mice exposed to tMCAO on the contralateral hemisphere or the ipsilateral hemisphere (p = 0.93), however, in the brains of WT mice,
the expression was significantly higher in the ipsilateral hemisphere compared to the contralateral hemisphere (∗p = 0.017). This difference was not observed in the
brains of BID-KO mice. The white arrow marks an IBA1 positive cell. The pictures were taken from normal appearing cortex. Scale bars: 60 µm (n = 5–6 in each
group, 2-way ANOVA, mean ± SD). (B) The relative mRNA expression of CD38 was significantly higher in BID-KO mice compared to WT mice exposed to tMCAO
24 h after surgery (∗p = 0.05, n = 3 in each sham group, n = 5–6 in each tMCAO group, 2-way ANOVA, mean ± SD). (C) The relative mRNA expression level of
CD11b was not quite upregulated 24 h after surgery (p = 0.073), and there was no significant difference between BID-KO and WT sham mice or between BID-KO
and WT tMCAO mice (p = 0.87, n = 3 in each sham group, n = 5–6 in each tMCAO group, 2-way ANOVA, mean ± SD).
and the contralateral hemisphere ofmice exposed to tMCAO.We
detected no difference in the number of GFAP+ cells between the
two hemispheres (p = 0.52) or between BID-KO and WT mice
(p = 0.23; Figure 7A).
In addition to immunohistochemistry, Western blotting for
GFAP was performed on whole brain lysates from both tMCAO
and sham mice. We observed astroglial activation in both
BID-KO and WT mice subjected to tMCAO, as evidenced by
the GFAP expression pattern revealing isotypes known to be
expressed by activated astrocytes (Kamphuis et al., 2012). These
were not present in the sham-operated mice (Figure 7B). In
conclusion, our result suggests that BID deficiency does not affect
astroglial activation in response to tMCAO.
Expression of Inflammatory Markers
The expression level of various cytokines and chemokines
were analyzed on protein level by mesoscale multiplex
analysis of pooled protein samples. As expected, we
observed an increase in expression level of the examined
cytokines in response to tMCAO. As this analysis was
carried out with pooled samples, statistics cannot be
performed, but there was a clear tendency that the examined
cytokines and chemokines were reduced in BID-KO mice
exposed to tMCAO compared to WT mice. IL-6 levels
were found to be reduced by ∼45%, CXCL1 by ∼30%,
IL-1β by ∼28% and TNF by ∼16%. In the case of IL-10
protein, we noted no considerable difference between
the groups (∼9% lower in BID-KO mice; Figure 8). The
expression level of the cytokines and chemokines were
in addition analyzed on mRNA level by qPCR. Here we
did not find a similar expression pattern, and there was
no significant difference between BID-KO mice and WT
mice for any of the examined cytokines and chemokines
(Figure 8).
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FIGURE 7 | Astrocyte response after transient middle cerebral artery occlusion (tMCAO). (A) When we compared the number of GFAP positive cells per
field of view between BID-KO mice and WT mice exposed to tMCAO, we found no difference between the ipsilateral and the contralateral hemisphere of either of the
two groups of mice (p = 0.52) or between the two groups of mice at any of the hemispheres (p = 0.23). The white arrow marks a GFAP positive cell. The pictures
were taken in the normal appearing cortex. Scale bars: 30 µm (n = 5–6 in each group, 2-way ANOVA, mean ± SD). (B) Western blot performed on whole brain
lysate showed an activation of GFAP in both BID-KO mice and WT mice exposed to tMCAO as indicated by the expression pattern of the various isotypes of GFAP
compared to sham mice.
The MAPK and NF-κB signaling cascades are known to be
important in innate immunity and inflammation (Chen et al.,
2001; Kyriakis and Avruch, 2012) and they have been shown to
be downregulated in BID deficient compared to WT cell cultures
following inflammatory stimuli exposure (Yeretssian et al., 2011).
We examined the expression of the phosphorylated MAPKs
pERK1/2, pJNK1/2 and pp38, and the NF-κB signaling pathway
component pIKKα/β by Western blotting performed on protein
extractions from whole brain lysate. The obtained results in these
analyses did not reveal a difference between the two groups
(Figure 9).
DISCUSSION
The present study demonstrated a neuroprotective effect of
BID deficiency against OGD-induced neuronal injury in vitro,
yet we did not find a significant effect of BID deficiency on
lesion volume or functional outcome in response to tMCAO
in vivo. We also examined the effect of BID deficiency
on the inflammatory responses to focal ischemia in vivo.
We found that BID modulated inflammation after tMCAO;
Microglial/leukocyte response was reduced in BID-KO mice
as indicated by changes in IBA1 and CD38 expression, and
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FIGURE 8 | Expression of cytokines and chemokines. The expression level of various cytokines and chemokines were evaluated on protein level by mesoscale
multiplex analysis of pooled samples (pool from 3 mice in each sham group, and 5–6 mice in each tMCAO group), and on mRNA by qPCR of non-pooled samples.
As expected, the expression was generally elevated after tMCAO on both protein and mRNA level (∗p < 0.05, ∗∗p < 0.01, ##p < 0.01, ###p < 0.001). When
comparing the expression between the two groups of mice after tMCAO there was an overall reduction in protein levels in the BID-KO mice compared to WT mice.
The biggest reduction of expression in BID-KO mice was found for IL-6 which was reduced by ∼45%. For CXCL1 protein the expression was reduced by ∼30%,
IL-1β protein by ∼28%, TNF protein by ∼16% and IL-10 protein by ∼9%. However, all cytokines and chemokines were not reduced in BID-KO mice compared to
WT mice on mRNA level, and there was no significant difference for any of the examined cytokines and chemokines (IL-6: p = 0.65, IL-1β: p = 0.27, CXCL1: p = 0.7,
TNF: p = 0.33, IL-10: p = 0.33, 2-way ANOVA, mean ± SD).
the overall level of inflammatory cytokines and chemokine
protein was reduced in BID-KO mice compared to WT
mice.
Apoptosis contributes significantly to cell death after stroke
(Mergenthaler et al., 2004; Lorz and Mehmet, 2009). It is
well established that BID is a proapoptotic protein (Wang
et al., 1996; Chung et al., 2010) and two previously published
studies using a different genetic strain have shown that BID-
KO mice developed smaller infarcts than WT mice (Plesnila
et al., 2001; Yin et al., 2002). Using well-characterized BID-
deficient mice (Kaufmann et al., 2007; König et al., 2014) and
after careful evaluation of their cerebrovascular anatomy, we
did not find any difference in infarct volume between BID-
KO and WT mice after 60 min of transient focal cerebral
ischemia. The mean infarct volume of BID-KO mice actually
tended to be higher than the mean infarct volume of WT mice
(83.26 and 68.28 mm3 respectively). In addition, we did not
find any differences in the functional outcome between BID-
KO mice and WT mice. A recent study from our laboratory
demonstrated a robust protection against tMCAO induced
neuronal injury as a result of BAX gene deletion (D’Orsi et al.,
2015). As BID is acting upstream of BAX in cell death signaling,
these results indicate that other upstream, proapoptotic BH3-
domain containing BCL-2 family proteins (‘‘BH3-only proteins’’)
such as BIM and PUMA may play a more predominant
role in BAX activation after cerebral ischemia (Ren et al.,
2010; Engel et al., 2011). A second interesting observation
in this regard came from our in vitro studies in OHSCs.
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FIGURE 9 | Expression of phosphorylated signaling pathway components. (A) The level of phosphorylated NF-κB upstream kinase IKKα/β was compared by
Western blotting and subsequent densitometry between BID-KO mice and WT mice on whole brain lysates 24 h after tMCAO. We found no difference between the
two groups of mice (p = 0.63). (B) This was also true for the phosphorylated MAP kinases JNK1/2 (pJNK1: p = 0.69, pJNK2: p = 0.78), (C) ERK1/2 (pERK1:
p = 0.57, pERK2: p = 0.5), and (D) p38 (p = 0.93). Probing for α-actin or TFIIB served as loading control (n = 4 in each group, non-paired t-test, mean ± SD).
Here, exposure to the NMDA receptor antagonist MK-801
afforded robust protection against OGD-induced neuronal
injury in WT cultures, but failed to provide protection in
BID-KO cultures above that induced by BID deficiency. It is
therefore possible that BID modulates neuroprotective signaling
during excitotoxic injury. For example, inflammatory cytokines
(including IL-1β and IL-6) have previously been shown to
be protective against neuronal injury induced by NMDA
receptor overactivation (Carlson et al., 1999). A reduction
in IL-1β and IL-6 levels in BID-KO animals may impair
endogenous neuroprotective signaling through these cytokines.
It is therefore possible that any neuroprotection afforded by
reduced apoptotic signaling through themitochondrial apoptosis
pathway in the bid-deficient animals is cancelled out by
an inhibition og endogenous, pro-inflammatory signals that
promote neuroprotection.
BID-KO mice used in previous studies that have shown
an infarct reducing effect of BID deficiency originated from a
different mouse strain (Yin et al., 1999). This BID-KO strain was
generated on amixed C57BL6/Sv129 genetic background and the
mice genome still contained the drug selection cassette from the
targeted DNA locus (Yin et al., 1999). The mice strain employed
in the present study was generated in the Andreas Strasser
group on a pure C57BL/6 background, and the drug selection
cassette was removed by breeding with Cre-positive ‘‘deleter’’
females (Kaufmann et al., 2007). The difference between our
and previous studies could be a result of strain differences. It
has also been suggested that drug selection cassettes left in the
genome could affect expression of linked genes (Koyasu et al.,
1994). Interestingly, phenotypical differences between the two
different BID-KO mice strains have previously been described:
The mice utilized in the two previous studies have been observed
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to develop spontaneous myeloid leukemia as they age (Zinkel
et al., 2003). This was not observed for the mice in the present
study (Kaufmann et al., 2007). It should also be noted that the
models used in the two studies were slightly different from the
model applied in the present study. In the study by Plesnila et al.
(2001), mice were exposed to 30 min of ischemia and 48 h of
survival applying a model allowing only unilateral carotid artery
reperfusion. In the study by Yin et al. (2002), mice were exposed
to 90 min of ischemia and 72 h of survival, applying a model
allowing bilateral carotid artery reperfusion. The differences
in a potential BID involvement in ischemic neuronal injury
may therefore be a consequence of differences in excitotoxic
and/or inflammatory signaling between the different models
employed.
As it has previously been shown that BID affects the
inflammatory response both in vitro, and in vivo (Scatizzi
et al., 2007; Chung et al., 2010; Mayo et al., 2011; Yeretssian
et al., 2011; König et al., 2014), we therefore chose to look at
microglial/leukocyte activation in our model. Microglial cells are
known to contribute substantially to the elevation of cytokine
levels in the brain after focal cerebral ischemia (Lambertsen
et al., 2012) and the lack of IBA1 microglial/leukocyte activation
or recruitment in the ipsilateral hemisphere in BID-KO mice
observed in the present study may be responsible for a lower
levels of proinflammatory cytokines in BID-KO mice. However,
it should be mentioned that the increase in IBA1 positive
cells observed in WT mice was modest and statistical analysis
between the ipsilateral hemisphere of BID-KO mice and WT
mice did not reveal a significant difference. The elevation of
CD38 mRNA, which is mainly expressed by infiltrating cells
and has been found to contribute to tissue damage after focal
cerebral ischemia (Choe et al., 2011), and the lack of reduction
in mRNA levels of inflammatory cytokines and chemokines in
BID-KO mice exposed to tMCAO are at first glance conflicting
observations in this regard, and might be a result of unidentified
compensatory mechanisms. We do not see an elevation of
CD38 or CD11b mRNA at this time point in WT mice. This
is however not an unexpected finding as infiltration of cells
is known to be sparse 24 h after tMCAO (Schilling et al.,
2003).
Based on the data presented here, we suggest that the general
perception of BID as an important player of cell death after
focal cerebral ischemia should be interpreted with caution.While
we observed partial protection in an in vitro model of ischemic
neuronal injury in OHSC, we did not find evidence for a
robust protection against tMCAO in vivo. The modulation of
the inflammatory response observed for BID-KO mice in the
present study was not sufficient to influence infarct volume
or acute neurological scores in response to tMCAO. BID may
still be an interesting subject in the stroke context, as we here
show that BID modulates the inflammatory response to tMCAO.
Indeed, it is well established that the inflammatory response
plays an important role in the pathophysiology of recovery and
regeneration after stroke (Lambertsen et al., 2012).
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